Rapid Access to 2-Substituted Bicyclo[1.1.1]pentanes.


Journal

Journal of the American Chemical Society
ISSN: 1520-5126
Titre abrégé: J Am Chem Soc
Pays: United States
ID NLM: 7503056

Informations de publication

Date de publication:
08 Feb 2023
Historique:
pubmed: 26 1 2023
medline: 26 1 2023
entrez: 25 1 2023
Statut: ppublish

Résumé

The replacement of aryl rings with saturated carbocyclic structures has garnered significant interest in drug discovery due to the potential for improved pharmacokinetic properties upon substitution. In particular, 1,3-difunctionalized bicyclo[1.1.1]pentanes (BCPs) have been widely adopted as bioisosteres for parasubstituted arene rings, appearing in a number of lead pharmaceutical candidates. However, despite the pharmaceutical value of 2-substituted BCPs as replacements for ortho- or meta-substituted arene rings, general and rapid syntheses of these scaffolds remain elusive. Current approaches to 2-substituted BCPs rely on installation of the bridge substituent prior to BCP core construction, leading to lengthy step counts and often nonmodular sequences. While challenging, direct functionalization of the strong bridge BCP C-H bonds would offer a more streamlined pathway to diverse 2-substituted BCPs. Here, we report a generalizable synthetic linchpin strategy for bridge functionalization via radical C-H abstraction of the BCP core. Through mild generation of a strong hydrogen atom abstractor, we rapidly synthesize novel 2-substituted BCP synthetic linchpins in one pot. These synthetic linchpins then serve as common precursors to complex 2-substituted BCPs, allowing one-step access to a number of previously inaccessible electrophile and nucleophile fragments at the 2-position via two new metallaphotoredox protocols. Altogether, this platform enables the expedient synthesis of four pharmaceutical analogues, all of which show similar or improved properties compared to their aryl-containing equivalents, demonstrating the potential of these 2-substituted BCPs in drug development.

Identifiants

pubmed: 36696089
doi: 10.1021/jacs.2c12163
pmc: PMC10680143
mid: NIHMS1945405
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3092-3100

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM134897
Pays : United States

Références

J Org Chem. 2004 Apr 30;69(9):3129-38
pubmed: 15104452
Proc Natl Acad Sci U S A. 2021 Jul 13;118(28):
pubmed: 34244445
Acc Chem Res. 2003 Apr;36(4):255-63
pubmed: 12693923
Chem Rev. 2000 Jan 12;100(1):169-234
pubmed: 11749237
J Am Chem Soc. 2016 Jul 6;138(26):8084-7
pubmed: 27263662
J Am Chem Soc. 2020 Jul 8;142(27):11691-11697
pubmed: 32564602
Angew Chem Int Ed Engl. 2021 Nov 15;60(47):24754-24769
pubmed: 34151501
Nat Chem. 2021 Oct;13(10):950-955
pubmed: 34584254
ACS Med Chem Lett. 2016 Nov 15;8(1):43-48
pubmed: 28105273
J Org Chem. 2019 Mar 1;84(5):2448-2461
pubmed: 30675778
Chem Soc Rev. 2022 Mar 21;51(6):2171-2223
pubmed: 35229835
Chemistry. 2019 Mar 27;25(18):4590-4647
pubmed: 30387906
Nature. 2018 Jul;559(7712):83-88
pubmed: 29925943
J Am Chem Soc. 2019 May 1;141(17):6853-6858
pubmed: 30983333
Org Biomol Chem. 2019 Mar 13;17(11):2839-2849
pubmed: 30672560
Chem. 2021 Jul 8;7(7):1827-1842
pubmed: 34423174
Org Lett. 2020 Nov 20;22(22):9133-9138
pubmed: 33170018
J Org Chem. 2021 Aug 6;86(15):10303-10319
pubmed: 34269057
J Med Chem. 2012 Apr 12;55(7):3414-24
pubmed: 22420884
ACS Med Chem Lett. 2020 Feb 21;11(10):1785-1788
pubmed: 33062152
ChemMedChem. 2017 Apr 20;12(8):590-598
pubmed: 28319646
J Am Chem Soc. 2018 Dec 19;140(50):17433-17438
pubmed: 30516995
Nat Chem. 2018 Apr;10(4):383-394
pubmed: 29568051
ACS Med Chem Lett. 2020 Jul 15;11(8):1548-1554
pubmed: 32832022

Auteurs

Olivia L Garry (OL)

Merck Center for Catalysis at Princeton University, Princeton, New Jersey 08544, United States.

Michael Heilmann (M)

Merck Center for Catalysis at Princeton University, Princeton, New Jersey 08544, United States.

Jingjia Chen (J)

Merck Center for Catalysis at Princeton University, Princeton, New Jersey 08544, United States.

Yufan Liang (Y)

Merck Center for Catalysis at Princeton University, Princeton, New Jersey 08544, United States.

Xiaheng Zhang (X)

Merck Center for Catalysis at Princeton University, Princeton, New Jersey 08544, United States.

Xiaoshen Ma (X)

Department of Discovery Chemistry, Merck & Co., Inc., Boston, Massachusetts 02115, United States.

Charles S Yeung (CS)

Department of Discovery Chemistry, Merck & Co., Inc., Boston, Massachusetts 02115, United States.

David Jonathan Bennett (DJ)

Department of Discovery Chemistry, Merck & Co., Inc., Boston, Massachusetts 02115, United States.

David W C MacMillan (DWC)

Merck Center for Catalysis at Princeton University, Princeton, New Jersey 08544, United States.

Classifications MeSH